- Home
- Essential Oil Fractions
- Eucalyptus Oil Extract
Eucalyptus Oil Extract (Eucalyptus globulus) – Eucalyptol (1,8-cineole) 70–85%
Eucalyptus globulus
- Marker compound
- Eucalyptol (1,8-cineole)
- Standardisation
- 70–85% (GC)
- Assay method
- GC
- Plant part
- Leaf
- Origin
- Australia, China, India
Eucalyptus Oil Extract (Eucalyptus globulus) – Eucalyptol (1,8-cineole) 70–85%
Eucalyptus extract is produced from the leaf oil of Eucalyptus globulus (Myrtaceae family) and supplied as an essential-oil fraction, standardized to Eucalyptol (1,8-cineole). Available grades: Typical 70–85%. Typical sourcing: Australia, China, India. For B2B formulation in nutraceuticals & supplements.
Typical 70–85%
Specifications
| Botanical name | Eucalyptus globulus |
| Common names | Eucalyptus |
| Plant family / part | Myrtaceae / Leaf oil |
| Marker compound | Eucalyptol (1,8-cineole) |
| Phytochemical class | Volatile oil constituents › Monoterpenes & aromatic volatiles |
| Available grades | Typical 70–85% |
| Assay method | GC |
| Pharmacopoeia & standards | USP, Ph. Eur. (EP), EMA herbal monograph |
| Form | Essential Oil Fraction |
| Origin | Australia, China, India |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Immune Support
- Respiratory Health
Industries
Nutraceuticals & Supplements
Traditional systems: European herbal tradition
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form